CADL Financials
Candel Therapeutics Inc - Financial statements & key metrics
Stock Price
$12.85
Market Cap
$592.02M
P/E Ratio
-19.8
EPS
$-0.56
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-55.18M
EPS (Diluted)
$-1.74
Balance Sheet Highlights
Total Assets
$106.87M
Total Liabilities
$40.54M
Shareholders Equity
-
Cash & Equivalents
$102.65M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-27.02M
CapEx
-
Free Cash Flow
-
Profitability Metrics
ROE
-70.2%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is CADL revenue?
View CADL's income statement for detailed revenue data.
Is CADL profitable?
CADL reported a loss of $55.18M in the most recent quarter.
What is CADL market cap?
CADL has a market capitalization of $592.02M, making it a small-cap stock.
Does CADL have debt?
View CADL's balance sheet for debt information.
What is CADL cash flow?
Cash flow data is available in the full financial statements.